Crinetics Pharmaceuticals Inc. (CRNX) NASDAQ
$42.42 (0.90) (-2.08%)
Market Cap: $3.02B
As of 04/25/24 03:27 PM EDT. Market open.
Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ
$42.42
(0.90) (-2.08%)
Market Cap: $3.02B
As of 04/25/24 03:27 PM EDT. Market open.
Add to Portfolio
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
R. Scott Struthers
Full Time Employees
194
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
R. Scott Struthers
Full Time Employees
194
CEO Compensation (Base)
$409,913
CEO Compensation (Total)
$3.04M
Address
10222 Barnes Canyon Rd Bldg 2, California, San Diego, 92121-2711.
PRICE CHART FOR CRINETICS PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$42.76
Previous Close
$43.32
Days Range
$43.28 - $45.02
52 week range
$15.76 - $49.58
Volume
364,290
Avg. Volume (30 days)
836,361
Market Cap
$3.02B
Dividend Yield
-
P/E
(14.05)
Shares Outstanding
69,600,000
Open
$42.76
Previous Close
$43.32
Days Range
$43.28 - $45.02
52 week range
$15.76 - $49.58
Volume
364,290
Avg. Volume (30 days)
836,361
Market Cap
$3.02B
Dividend Yield
-
P/E
(14.05)
Shares Outstanding
69,600,000
FINANCIAL STATEMENTS FOR CRINETICS PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CRINETICS PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Pizzuti Dana | Chief Med and Dev Officer | Apr 15, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 42,161 | Apr 17, 2024, 04:36 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Apr 15, 2024 | Sale | $44.47 | 14,375 | 639,256 | 27,786 | Apr 17, 2024, 04:36 PM |
| Struthers Richard Scott | President & CEO | Apr 15, 2024 | Option Exercise | $1.91 | 20,000 | 38,200 | 257,835 | Apr 17, 2024, 04:30 PM |
| Struthers Richard Scott | President & CEO | Apr 04, 2024 | Option Exercise | $9.28 | 40,951 | 380,025 | 278,786 | Apr 08, 2024, 05:09 PM |
| Struthers Richard Scott | President & CEO | Apr 04, 2024 | Sale | $49.17 | 40,951 | 2,013,561 | 237,835 | Apr 08, 2024, 05:09 PM |
| Knight Jeff E. | Chief Operating Officer | Mar 22, 2024 | Option Exercise | $23.98 | 30,000 | 719,400 | 84,939 | Mar 26, 2024, 04:30 PM |
| Knight Jeff E. | Chief Operating Officer | Mar 22, 2024 | Sale | $44.31 | 32,359 | 1,433,675 | 54,939 | Mar 26, 2024, 04:30 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 38,500 | Mar 22, 2024, 04:52 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Mar 20, 2024 | Sale | $44.06 | 15,089 | 664,763 | 28,500 | Mar 22, 2024, 04:52 PM |
| Fust Matthew K | Director | Mar 20, 2024 | Option Exercise | $20.92 | 60,000 | 1,254,975 | 36,036 | Mar 22, 2024, 04:31 PM |
| Fust Matthew K | Director | Mar 20, 2024 | Sale | $44.14 | 60,000 | 2,648,150 | 18,536 | Mar 22, 2024, 04:31 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Mar 18, 2024 | Option Exercise | $38.14 | 411 | 15,676 | 28,500 | Mar 20, 2024, 06:36 PM |
| Knight Jeff E. | Chief Operating Officer | Mar 18, 2024 | Option Exercise | $38.14 | 4,283 | 163,354 | 54,939 | Mar 20, 2024, 06:35 PM |
| Hassard James | Chief Commercial Officer | Mar 18, 2024 | Option Exercise | $38.14 | 1,741 | 66,402 | 29,259 | Mar 20, 2024, 06:34 PM |
| Betz Stephen F. | Chief Scientific Officer | Mar 18, 2024 | Option Exercise | $38.14 | 3,655 | 139,402 | 92,643 | Mar 20, 2024, 06:33 PM |
| Wilson Marc | CFO | Mar 18, 2024 | Option Exercise | $38.14 | 3,983 | 151,912 | 117,572 | Mar 20, 2024, 06:32 PM |
| Wilson Marc | CFO | Mar 19, 2024 | Sale | $42.91 | 6,942 | 297,881 | 110,630 | Mar 20, 2024, 06:32 PM |
| Struthers Richard Scott | President & CEO | Mar 18, 2024 | Option Exercise | $38.14 | 12,687 | 483,882 | 237,835 | Mar 20, 2024, 06:31 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 25, 2024 | Sale | $37.26 | 3,000 | 111,780 | 73,298 | Jan 26, 2024, 05:50 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 10, 2024 | Sale | $37.65 | 3,000 | 112,950 | 76,298 | Jan 12, 2024, 04:12 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Option Exercise | $16.89 | 14,375 | 242,794 | 20,286 | Jan 04, 2024, 04:45 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Jan 03, 2024 | Sale | $35.00 | 14,375 | 503,125 | 5,911 | Jan 04, 2024, 04:45 PM |
| Wilson Marc | CFO | Jan 02, 2024 | Option Exercise | $9.28 | 10,000 | 92,800 | 106,055 | Jan 04, 2024, 04:43 PM |
| Wilson Marc | CFO | Jan 02, 2024 | Sale | $35.47 | 10,000 | 354,700 | 96,055 | Jan 04, 2024, 04:43 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 26, 2023 | Sale | $35.89 | 3,000 | 107,670 | 79,298 | Dec 27, 2023, 05:20 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Option Exercise | $16.89 | 9,583 | 161,857 | 15,494 | Dec 22, 2023, 06:45 PM |
| Pizzuti Dana | Chief Med and Dev Officer | Dec 21, 2023 | Sale | $34.57 | 9,583 | 331,284 | 5,911 | Dec 22, 2023, 06:45 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 11, 2023 | Sale | $32.87 | 3,000 | 98,610 | 82,298 | Dec 13, 2023, 04:44 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 27, 2023 | Sale | $31.84 | 3,000 | 95,520 | 85,298 | Nov 29, 2023, 04:31 PM |
| Struthers Richard Scott | President & CEO | Nov 09, 2023 | Option Exercise | $1.91 | 50,000 | 95,500 | 185,522 | Nov 13, 2023, 04:33 PM |
| Struthers Richard Scott | President & CEO | Nov 03, 2023 | Option Exercise | $9.28 | 199,082 | 1,847,481 | 334,604 | Nov 06, 2023, 06:02 PM |
| Struthers Richard Scott | President & CEO | Nov 02, 2023 | Option Exercise | $9.28 | 918 | 8,519 | 136,440 | Nov 06, 2023, 06:02 PM |
| Struthers Richard Scott | President & CEO | Nov 03, 2023 | Sale | $30.56 | 199,082 | 6,083,946 | 135,522 | Nov 06, 2023, 06:02 PM |
| Struthers Richard Scott | President & CEO | Nov 02, 2023 | Sale | $29.95 | 918 | 27,494 | 135,522 | Nov 06, 2023, 06:02 PM |
| Wilson Marc | CFO | Nov 01, 2023 | Option Exercise | $9.28 | 10,000 | 92,800 | 105,601 | Nov 03, 2023, 07:38 PM |
| Wilson Marc | CFO | Nov 01, 2023 | Sale | $28.75 | 10,000 | 287,500 | 95,601 | Nov 03, 2023, 07:38 PM |
| Krasner Alan Seth | Chief Medical Officer | Oct 17, 2023 | Option Exercise | $12.01 | 7,000 | 84,070 | 50,210 | Oct 19, 2023, 05:01 PM |
| Krasner Alan Seth | Chief Medical Officer | Oct 17, 2023 | Sale | $30.00 | 7,000 | 210,000 | 43,210 | Oct 19, 2023, 05:01 PM |
| Struthers Richard Scott | President & CEO | Aug 14, 2023 | Option Exercise | $1.91 | 10,000 | 19,100 | 135,522 | Aug 16, 2023, 04:30 PM |
| Struthers Richard Scott | President & CEO | Jul 13, 2023 | Sale | $20.35 | 14,157 | 288,095 | 630,805 | Jul 13, 2023, 04:56 PM |
| Struthers Richard Scott | President & CEO | Jul 12, 2023 | Sale | $20.17 | 11,459 | 231,128 | 644,962 | Jul 13, 2023, 04:56 PM |
| Struthers Richard Scott | President & CEO | Jul 11, 2023 | Sale | $20.14 | 24,384 | 491,094 | 656,421 | Jul 13, 2023, 04:56 PM |
| Wilson Marc | CFO | Jun 20, 2023 | Option Exercise | $9.28 | 20,000 | 185,600 | 115,158 | Jun 21, 2023, 05:32 PM |
| Wilson Marc | CFO | Jun 20, 2023 | Sale | $19.97 | 30,922 | 617,403 | 95,158 | Jun 21, 2023, 05:32 PM |
| Struthers Richard Scott | President & CEO | Jun 16, 2023 | Sale | $20.81 | 50,000 | 1,040,500 | 680,805 | Jun 21, 2023, 05:27 PM |
| Vivaldi Coelho Rogerio | Director | Jun 08, 2023 | Buy | $22.06 | 5,000 | 110,300 | 5,000 | Jun 09, 2023, 08:00 AM |
| Pizzuti Dana | Chief Development Officer | Apr 03, 2023 | Option Exercise | $15.98 | 4,288 | 68,522 | 12,712 | Apr 05, 2023, 07:12 PM |
| Pizzuti Dana | Chief Development Officer | Apr 05, 2023 | Sale | $16.15 | 8,212 | 132,624 | 4,500 | Apr 05, 2023, 07:12 PM |
| Wilson Marc | CFO | Mar 16, 2023 | Option Exercise | $17.12 | 1,666 | 28,522 | 106,080 | Mar 17, 2023, 05:11 PM |
| Struthers Richard Scott | President & CEO | Mar 16, 2023 | Option Exercise | $17.12 | 4,628 | 79,231 | 125,522 | Mar 17, 2023, 05:10 PM |
| Krasner Alan Seth | Chief Medical Officer | Mar 16, 2023 | Option Exercise | $17.12 | 1,687 | 28,881 | 42,301 | Mar 17, 2023, 05:09 PM |
| Knight Jeff E. | Chief Operating Officer | Mar 16, 2023 | Option Exercise | $17.12 | 587 | 10,049 | 34,400 | Mar 17, 2023, 05:08 PM |
| Betz Stephen F. | Chief Scientific Officer | Mar 16, 2023 | Option Exercise | $17.12 | 1,410 | 24,139 | 86,879 | Mar 17, 2023, 05:07 PM |
| Betz Stephen F. | Chief Scientific Officer | Feb 01, 2023 | Sale | $19.59 | 3,126 | 61,238 | 64,689 | Feb 03, 2023, 04:30 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 25, 2023 | Sale | $21.07 | 8,336 | 175,640 | 67,815 | Jan 27, 2023, 04:26 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 17, 2023 | Sale | $18.00 | 3,126 | 56,268 | 76,151 | Jan 19, 2023, 04:28 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 03, 2023 | Sale | $18.35 | 3,126 | 57,362 | 79,277 | Jan 05, 2023, 04:23 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 15, 2022 | Sale | $16.00 | 3,126 | 50,016 | 82,403 | Dec 19, 2022, 05:11 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 01, 2022 | Sale | $17.84 | 3,126 | 55,768 | 84,968 | Dec 05, 2022, 05:28 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 15, 2022 | Sale | $18.72 | 3,126 | 58,519 | 88,094 | Nov 17, 2022, 04:46 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 01, 2022 | Sale | $18.52 | 3,126 | 57,894 | 91,220 | Nov 03, 2022, 04:35 PM |
| Betz Stephen F. | Chief Scientific Officer | Oct 17, 2022 | Sale | $17.73 | 3,126 | 55,424 | 94,346 | Oct 19, 2022, 05:34 PM |
| Struthers Richard Scott | President & CEO | Oct 12, 2022 | Option Exercise | $1.91 | 11,100 | 21,201 | 68,500 | Oct 14, 2022, 04:55 PM |
| Betz Stephen F. | Chief Scientific Officer | Oct 03, 2022 | Sale | $19.64 | 3,126 | 61,395 | 97,472 | Oct 05, 2022, 04:40 PM |
| Betz Stephen F. | Chief Scientific Officer | Sep 15, 2022 | Sale | $21.01 | 4,168 | 87,570 | 100,598 | Sep 19, 2022, 04:40 PM |
| Betz Stephen F. | Chief Scientific Officer | Sep 07, 2022 | Sale | $21.00 | 1,042 | 21,884 | 104,766 | Sep 09, 2022, 04:20 PM |
| Betz Stephen F. | Chief Scientific Officer | May 20, 2022 | Option Exercise | $11.02 | 1,336 | 14,723 | 108,934 | Sep 06, 2022, 04:20 PM |
| Betz Stephen F. | Chief Scientific Officer | Sep 01, 2022 | Sale | $18.59 | 3,126 | 58,112 | 105,808 | Sep 06, 2022, 04:20 PM |
| Knight Jeff E. | Chief Operating Officer | May 20, 2022 | Option Exercise | $17.44 | 1,152 | 20,091 | 6,102 | Jul 29, 2022, 04:26 PM |
| Knight Jeff E. | Chief Operating Officer | Jul 26, 2022 | Sale | $20.70 | 1,152 | 23,847 | 4,950 | Jul 29, 2022, 04:26 PM |
| Fust Matthew K | Director | Jul 13, 2022 | Option Exercise | $1.45 | 5,700 | 8,265 | 18,236 | Jul 15, 2022, 04:30 PM |
| Fust Matthew K | Director | Jul 13, 2022 | Sale | $20.96 | 5,700 | 119,455 | 12,536 | Jul 15, 2022, 04:30 PM |
| Betz Stephen F. | Chief Scientific Officer | May 02, 2022 | Sale | $20.10 | 3,247 | 65,252 | 107,598 | May 04, 2022, 05:01 PM |
| Betz Stephen F. | Chief Scientific Officer | Apr 18, 2022 | Sale | $25.81 | 5,664 | 146,188 | 110,845 | Apr 21, 2022, 05:00 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 18, 2022 | Buy | $22.22 | 157,515 | 3,499,983 | 5,321,032 | Apr 18, 2022, 05:39 PM |
| Struthers Richard Scott | President & CEO | Apr 13, 2022 | Sale | $26.83 | 138,643 | 3,719,625 | 844,774 | Apr 15, 2022, 06:00 PM |
| Struthers Richard Scott | President & CEO | Apr 05, 2022 | Sale | $25.34 | 21,357 | 541,225 | 869,448 | Apr 07, 2022, 05:58 PM |
| Betz Stephen F. | Chief Scientific Officer | Apr 04, 2022 | Sale | $23.97 | 9,000 | 215,761 | 116,509 | Apr 06, 2022, 07:08 PM |
| Betz Stephen F. | Chief Scientific Officer | Apr 01, 2022 | Sale | $21.80 | 4,164 | 90,775 | 125,509 | Apr 01, 2022, 05:39 PM |
| Betz Stephen F. | Chief Scientific Officer | Mar 31, 2022 | Sale | $21.06 | 4,164 | 87,700 | 129,673 | Apr 01, 2022, 05:39 PM |
| Betz Stephen F. | Chief Scientific Officer | Mar 15, 2022 | Sale | $18.94 | 3,123 | 59,150 | 133,837 | Mar 17, 2022, 04:33 PM |
| Madan Ajay | Chief Development Officer | Mar 01, 2022 | Sale | $19.88 | 9,000 | 178,920 | 176,995 | Mar 02, 2022, 09:00 PM |
| Betz Stephen F. | Chief Scientific Officer | Mar 01, 2022 | Sale | $19.73 | 3,123 | 61,617 | 136,960 | Mar 02, 2022, 09:00 PM |
| Betz Stephen F. | Chief Scientific Officer | Feb 15, 2022 | Sale | $18.64 | 3,123 | 58,213 | 123,583 | Feb 17, 2022, 04:34 PM |
| Madan Ajay | Chief Development Officer | Feb 07, 2022 | Sale | $17.83 | 13,411 | 239,085 | 172,045 | Feb 09, 2022, 05:00 PM |
| Betz Stephen F. | Chief Scientific Officer | Feb 01, 2022 | Sale | $18.79 | 3,123 | 58,681 | 126,706 | Feb 03, 2022, 04:30 PM |
| Krasner Alan Seth | Chief Medical Officer | Jan 19, 2022 | Option Exercise | $12.01 | 6,700 | 80,467 | 15,011 | Jan 21, 2022, 04:54 PM |
| Krasner Alan Seth | Chief Medical Officer | Jan 19, 2022 | Sale | $21.21 | 6,700 | 142,080 | 8,311 | Jan 21, 2022, 04:54 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 18, 2022 | Sale | $23.29 | 4,168 | 97,073 | 128,875 | Jan 20, 2022, 04:47 PM |
| Betz Stephen F. | Chief Scientific Officer | Jan 03, 2022 | Sale | $28.02 | 7,168 | 200,847 | 133,043 | Jan 06, 2022, 04:37 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 28, 2021 | Sale | $27.95 | 3,000 | 83,852 | 140,211 | Dec 30, 2021, 07:19 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 15, 2021 | Sale | $24.14 | 5,668 | 136,826 | 143,211 | Dec 17, 2021, 04:28 PM |
| Betz Stephen F. | Chief Scientific Officer | Dec 01, 2021 | Sale | $27.38 | 5,668 | 155,190 | 148,879 | Dec 03, 2021, 04:36 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 16, 2021 | Sale | $27.97 | 1,500 | 41,955 | 154,547 | Nov 17, 2021, 05:01 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 15, 2021 | Sale | $26.75 | 5,668 | 151,619 | 156,047 | Nov 17, 2021, 05:01 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 08, 2021 | Sale | $28.42 | 3,900 | 110,846 | 161,715 | Nov 09, 2021, 05:44 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 05, 2021 | Sale | $27.95 | 12,600 | 352,195 | 165,615 | Nov 09, 2021, 05:44 PM |
| Betz Stephen F. | Chief Scientific Officer | Nov 01, 2021 | Sale | $24.79 | 5,668 | 140,510 | 178,215 | Nov 03, 2021, 04:57 PM |
| Fust Matthew K | Director | Nov 01, 2021 | Option Exercise | $1.91 | 8,954 | 17,102 | 21,490 | Nov 03, 2021, 04:55 PM |
| Fust Matthew K | Director | Nov 01, 2021 | Sale | $25.50 | 8,954 | 228,327 | 12,536 | Nov 03, 2021, 04:55 PM |
| Madan Ajay | Chief Development Officer | Oct 28, 2021 | Option Exercise | $0.73 | 106,383 | 77,660 | 184,671 | Nov 01, 2021, 07:11 PM |
| Betz Stephen F. | Chief Scientific Officer | Oct 27, 2021 | Sale | $24.00 | 3,000 | 71,991 | 183,883 | Oct 28, 2021, 05:00 PM |
| Betz Stephen F. | Chief Scientific Officer | Oct 21, 2021 | Sale | $21.10 | 1,042 | 21,984 | 186,883 | Oct 25, 2021, 04:28 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Oct 25, 2021 | Buy | $19.80 | 1,200,000 | 23,759,999 | 5,163,517 | Oct 25, 2021, 02:47 PM |
| Fust Matthew K | Director | Sep 08, 2021 | Option Exercise | $1.91 | 6,046 | 11,548 | 18,582 | Sep 09, 2021, 05:00 PM |
| Fust Matthew K | Director | Sep 08, 2021 | Sale | $25.50 | 6,046 | 154,173 | 12,536 | Sep 09, 2021, 05:00 PM |
| Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
| Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
| Struthers Richard Scott | President & CEO | Sep 07, 2021 | Sale | $25.00 | 10,000 | 250,000 | 90,000 | Sep 09, 2021, 05:00 PM |
| Fust Matthew K | Director | Jul 26, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 27, 2021, 08:00 PM |
| Fust Matthew K | Director | Jul 26, 2021 | Sale | $19.59 | 5,000 | 97,950 | 12,536 | Jul 27, 2021, 08:00 PM |
| Fust Matthew K | Director | Jul 19, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 20, 2021, 05:00 PM |
| Fust Matthew K | Director | Jul 19, 2021 | Sale | $19.50 | 5,000 | 97,500 | 12,536 | Jul 20, 2021, 05:00 PM |
| Fust Matthew K | Director | Jul 12, 2021 | Option Exercise | $1.91 | 5,000 | 9,550 | 17,536 | Jul 13, 2021, 05:00 PM |
| Fust Matthew K | Director | Jul 12, 2021 | Sale | $20.71 | 5,000 | 103,550 | 12,536 | Jul 13, 2021, 05:00 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 08, 2021 | Buy | $16.44 | 304,136 | 4,999,996 | 3,963,517 | Apr 09, 2021, 09:00 AM |
| Struthers Richard Scott | President & CEO | Dec 02, 2020 | Buy | $12.60 | 1,000 | 12,600 | 1,000 | Dec 04, 2020, 04:59 PM |
| Struthers Richard Scott | President & CEO | Dec 03, 2020 | Buy | $13.10 | 4,000 | 52,400 | 4,000 | Dec 04, 2020, 04:59 PM |
| Struthers Richard Scott | President & CEO | Jul 16, 2020 | Sale | $14.46 | 17,500 | 253,108 | 890,805 | Jul 17, 2020, 05:05 PM |
| Struthers Richard Scott | President & CEO | Jul 15, 2020 | Sale | $15.30 | 17,500 | 267,722 | 908,305 | Jul 17, 2020, 05:05 PM |
| WIERENGA WENDALL | Director | Apr 28, 2020 | Option Exercise | $0.73 | 25,329 | 18,490 | 99,846 | Apr 29, 2020, 05:01 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Apr 17, 2020 | Buy | $14.00 | 1,071,428 | 14,999,992 | 3,659,381 | Apr 20, 2020, 08:30 AM |
| Vivo Capital VIII, LLC | 10% Owner | Apr 15, 2020 | Sale | $15.50 | 215,810 | 3,345,055 | 2,263,447 | Apr 17, 2020, 06:38 PM |
| Vivo Capital VIII, LLC | 10% Owner | Apr 17, 2020 | Sale | $15.40 | 84,598 | 1,302,809 | 2,162,587 | Apr 17, 2020, 06:38 PM |
| Vivo Capital VIII, LLC | 10% Owner | Apr 16, 2020 | Sale | $15.20 | 30,190 | 458,888 | 2,236,920 | Apr 17, 2020, 06:38 PM |
| Vivo Capital VIII, LLC | 10% Owner | Apr 07, 2020 | Sale | $14.20 | 6,115 | 86,833 | 2,453,072 | Apr 07, 2020, 07:27 PM |
| Vivo Capital VIII, LLC | 10% Owner | Apr 03, 2020 | Sale | $13.80 | 300,000 | 4,140,000 | 2,458,445 | Apr 07, 2020, 07:27 PM |
| Vivo Capital VIII, LLC | 10% Owner | Mar 09, 2020 | Sale | $19.50 | 528 | 10,296 | 2,722,045 | Mar 11, 2020, 05:12 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 10, 2020 | Sale | $21.40 | 7,555 | 161,677 | 2,722,392 | Feb 11, 2020, 08:00 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 07, 2020 | Sale | $22.00 | 5,905 | 129,910 | 2,723,843 | Feb 11, 2020, 08:00 PM |
| Vivo Capital VIII, LLC | 10% Owner | Feb 04, 2020 | Sale | $22.80 | 13,460 | 306,888 | 2,724,977 | Feb 06, 2020, 07:22 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jan 31, 2020 | Sale | $21.70 | 5,400 | 117,180 | 2,727,561 | Jan 31, 2020, 08:00 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jan 30, 2020 | Sale | $22.10 | 7,600 | 167,960 | 2,728,598 | Jan 31, 2020, 08:00 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jan 29, 2020 | Sale | $22.20 | 13,920 | 309,024 | 2,730,057 | Jan 31, 2020, 08:00 PM |
| Fust Matthew K | Director | Dec 16, 2019 | Option Exercise | $1.91 | 3,500 | 6,685 | 16,036 | Dec 18, 2019, 06:32 PM |
| Fust Matthew K | Director | Dec 16, 2019 | Sale | $22.50 | 3,500 | 78,750 | 12,536 | Dec 18, 2019, 06:32 PM |
| Struthers Richard Scott | President & CEO | Aug 05, 2019 | Option Exercise | $1.91 | 10,000 | 19,100 | 1,225,805 | Aug 07, 2019, 07:31 PM |
| 5AM Ventures IV, L.P. | Former 10% holder | Jun 21, 2019 | Sale | $22.20 | 250,000 | 5,550,000 | 2,267,797 | Jun 25, 2019, 07:03 PM |
| Vivo Capital VIII, LLC | 10% Owner | Mar 20, 2019 | Sale | $22.25 | 417,000 | 9,278,250 | 2,732,730 | Mar 25, 2019, 06:04 AM |
| 5AM Ventures IV, L.P. | 10% Owner | Mar 18, 2019 | Sale | $24.25 | 154,839 | 3,754,954 | 2,507,797 | Mar 20, 2019, 04:48 PM |
| 5AM Ventures IV, L.P. | 10% Owner | Jan 22, 2019 | Sale | $21.88 | 262,153 | 5,734,597 | 3,107,642 | Jan 24, 2019, 07:01 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 20, 2018 | Buy | $17.00 | 400,000 | 6,800,000 | 2,587,953 | Aug 27, 2018, 06:12 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 18, 2018 | Buy | $21.30 | 307,648 | 6,552,902 | 307,648 | Aug 27, 2018, 06:12 PM |
| 5AM Ventures IV, L.P. | 10% Owner | Jul 20, 2018 | Buy | $17.00 | 115,000 | 1,955,000 | 3,359,309 | Jul 20, 2018, 07:02 PM |
| PERCEPTIVE ADVISORS LLC | Director | Jul 20, 2018 | Buy | $17.00 | 400,000 | 6,800,000 | 2,280,305 | Jul 20, 2018, 05:19 PM |
| Vivo Capital VIII, LLC | 10% Owner | Jul 20, 2018 | Buy | $18.62 | 353,180 | 6,575,421 | 3,025,339 | Jul 20, 2018, 04:50 PM |
| Krasner Alan Seth | Chief Medical Officer | Jul 20, 2018 | Buy | $17.00 | 2,000 | 34,000 | 2,000 | Jul 20, 2018, 04:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Pizzuti Dana | Chief Med and Dev Officer | 04/15/2024 | 242,794 |
| Pizzuti Dana | Chief Med and Dev Officer | 04/15/2024 | 639,256 |
| Struthers Richard Scott | President & CEO | 04/15/2024 | 38,200 |
| Struthers Richard Scott | President & CEO | 04/04/2024 | 380,025 |
| Struthers Richard Scott | President & CEO | 04/04/2024 | 2,013,561 |
| Knight Jeff E. | Chief Operating Officer | 03/22/2024 | 719,400 |
| Knight Jeff E. | Chief Operating Officer | 03/22/2024 | 1,433,675 |
| Pizzuti Dana | Chief Med and Dev Officer | 03/20/2024 | 242,794 |
| Pizzuti Dana | Chief Med and Dev Officer | 03/20/2024 | 664,763 |
| Fust Matthew K | Director | 03/20/2024 | 1,254,975 |
| Fust Matthew K | Director | 03/20/2024 | 2,648,150 |
| Pizzuti Dana | Chief Med and Dev Officer | 03/18/2024 | 15,676 |
| Knight Jeff E. | Chief Operating Officer | 03/18/2024 | 163,354 |
| Hassard James | Chief Commercial Officer | 03/18/2024 | 66,402 |
| Betz Stephen F. | Chief Scientific Officer | 03/18/2024 | 139,402 |
| Wilson Marc | CFO | 03/18/2024 | 151,912 |
| Wilson Marc | CFO | 03/19/2024 | 297,881 |
| Struthers Richard Scott | President & CEO | 03/18/2024 | 483,882 |
| Betz Stephen F. | Chief Scientific Officer | 01/25/2024 | 111,780 |
| Betz Stephen F. | Chief Scientific Officer | 01/10/2024 | 112,950 |
| Pizzuti Dana | Chief Med and Dev Officer | 01/03/2024 | 242,794 |
| Pizzuti Dana | Chief Med and Dev Officer | 01/03/2024 | 503,125 |
| Wilson Marc | CFO | 01/02/2024 | 92,800 |
| Wilson Marc | CFO | 01/02/2024 | 354,700 |
| Betz Stephen F. | Chief Scientific Officer | 12/26/2023 | 107,670 |
| Pizzuti Dana | Chief Med and Dev Officer | 12/21/2023 | 161,857 |
| Pizzuti Dana | Chief Med and Dev Officer | 12/21/2023 | 331,284 |
| Betz Stephen F. | Chief Scientific Officer | 12/11/2023 | 98,610 |
| Betz Stephen F. | Chief Scientific Officer | 11/27/2023 | 95,520 |
| Struthers Richard Scott | President & CEO | 11/09/2023 | 95,500 |
| Struthers Richard Scott | President & CEO | 11/03/2023 | 1,847,481 |
| Struthers Richard Scott | President & CEO | 11/02/2023 | 8,519 |
| Struthers Richard Scott | President & CEO | 11/03/2023 | 6,083,946 |
| Struthers Richard Scott | President & CEO | 11/02/2023 | 27,494 |
| Wilson Marc | CFO | 11/01/2023 | 92,800 |
| Wilson Marc | CFO | 11/01/2023 | 287,500 |
| Krasner Alan Seth | Chief Medical Officer | 10/17/2023 | 84,070 |
| Krasner Alan Seth | Chief Medical Officer | 10/17/2023 | 210,000 |
| Struthers Richard Scott | President & CEO | 08/14/2023 | 19,100 |
| Struthers Richard Scott | President & CEO | 07/13/2023 | 288,095 |
| Struthers Richard Scott | President & CEO | 07/12/2023 | 231,128 |
| Struthers Richard Scott | President & CEO | 07/11/2023 | 491,094 |
| Wilson Marc | CFO | 06/20/2023 | 185,600 |
| Wilson Marc | CFO | 06/20/2023 | 617,403 |
| Struthers Richard Scott | President & CEO | 06/16/2023 | 1,040,500 |
| Vivaldi Coelho Rogerio | Director | 06/08/2023 | 110,300 |
| Pizzuti Dana | Chief Development Officer | 04/03/2023 | 68,522 |
| Pizzuti Dana | Chief Development Officer | 04/05/2023 | 132,624 |
| Wilson Marc | CFO | 03/16/2023 | 28,522 |
| Struthers Richard Scott | President & CEO | 03/16/2023 | 79,231 |
| Krasner Alan Seth | Chief Medical Officer | 03/16/2023 | 28,881 |
| Knight Jeff E. | Chief Operating Officer | 03/16/2023 | 10,049 |
| Betz Stephen F. | Chief Scientific Officer | 03/16/2023 | 24,139 |
| Betz Stephen F. | Chief Scientific Officer | 02/01/2023 | 61,238 |
| Betz Stephen F. | Chief Scientific Officer | 01/25/2023 | 175,640 |
| Betz Stephen F. | Chief Scientific Officer | 01/17/2023 | 56,268 |
| Betz Stephen F. | Chief Scientific Officer | 01/03/2023 | 57,362 |
| Betz Stephen F. | Chief Scientific Officer | 12/15/2022 | 50,016 |
| Betz Stephen F. | Chief Scientific Officer | 12/01/2022 | 55,768 |
| Betz Stephen F. | Chief Scientific Officer | 11/15/2022 | 58,519 |
| Betz Stephen F. | Chief Scientific Officer | 11/01/2022 | 57,894 |
| Betz Stephen F. | Chief Scientific Officer | 10/17/2022 | 55,424 |
| Struthers Richard Scott | President & CEO | 10/12/2022 | 21,201 |
| Betz Stephen F. | Chief Scientific Officer | 10/03/2022 | 61,395 |
| Betz Stephen F. | Chief Scientific Officer | 09/15/2022 | 87,570 |
| Betz Stephen F. | Chief Scientific Officer | 09/07/2022 | 21,884 |
| Betz Stephen F. | Chief Scientific Officer | 05/20/2022 | 14,723 |
| Betz Stephen F. | Chief Scientific Officer | 09/01/2022 | 58,112 |
| Knight Jeff E. | Chief Operating Officer | 05/20/2022 | 20,091 |
| Knight Jeff E. | Chief Operating Officer | 07/26/2022 | 23,847 |
| Fust Matthew K | Director | 07/13/2022 | 8,265 |
| Fust Matthew K | Director | 07/13/2022 | 119,455 |
| Betz Stephen F. | Chief Scientific Officer | 05/02/2022 | 65,252 |
| Betz Stephen F. | Chief Scientific Officer | 04/18/2022 | 146,188 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 04/18/2022 | 3,499,983 |
| Struthers Richard Scott | President & CEO | 04/13/2022 | 3,719,625 |
| Struthers Richard Scott | President & CEO | 04/05/2022 | 541,225 |
| Betz Stephen F. | Chief Scientific Officer | 04/04/2022 | 215,761 |
| Betz Stephen F. | Chief Scientific Officer | 04/01/2022 | 90,775 |
| Betz Stephen F. | Chief Scientific Officer | 03/31/2022 | 87,700 |
| Betz Stephen F. | Chief Scientific Officer | 03/15/2022 | 59,150 |
| Madan Ajay | Chief Development Officer | 03/01/2022 | 178,920 |
| Betz Stephen F. | Chief Scientific Officer | 03/01/2022 | 61,617 |
| Betz Stephen F. | Chief Scientific Officer | 02/15/2022 | 58,213 |
| Madan Ajay | Chief Development Officer | 02/07/2022 | 239,085 |
| Betz Stephen F. | Chief Scientific Officer | 02/01/2022 | 58,681 |
| Krasner Alan Seth | Chief Medical Officer | 01/19/2022 | 80,467 |
| Krasner Alan Seth | Chief Medical Officer | 01/19/2022 | 142,080 |
| Betz Stephen F. | Chief Scientific Officer | 01/18/2022 | 97,073 |
| Betz Stephen F. | Chief Scientific Officer | 01/03/2022 | 200,847 |
| Betz Stephen F. | Chief Scientific Officer | 12/28/2021 | 83,852 |
| Betz Stephen F. | Chief Scientific Officer | 12/15/2021 | 136,826 |
| Betz Stephen F. | Chief Scientific Officer | 12/01/2021 | 155,190 |
| Betz Stephen F. | Chief Scientific Officer | 11/16/2021 | 41,955 |
| Betz Stephen F. | Chief Scientific Officer | 11/15/2021 | 151,619 |
| Betz Stephen F. | Chief Scientific Officer | 11/08/2021 | 110,846 |
| Betz Stephen F. | Chief Scientific Officer | 11/05/2021 | 352,195 |
| Betz Stephen F. | Chief Scientific Officer | 11/01/2021 | 140,510 |
| Fust Matthew K | Director | 11/01/2021 | 17,102 |
| Fust Matthew K | Director | 11/01/2021 | 228,327 |
| Madan Ajay | Chief Development Officer | 10/28/2021 | 77,660 |
| Betz Stephen F. | Chief Scientific Officer | 10/27/2021 | 71,991 |
| Betz Stephen F. | Chief Scientific Officer | 10/21/2021 | 21,984 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 10/25/2021 | 23,759,999 |
| Fust Matthew K | Director | 09/08/2021 | 11,548 |
| Fust Matthew K | Director | 09/08/2021 | 154,173 |
| Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
| Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
| Struthers Richard Scott | President & CEO | 09/07/2021 | 250,000 |
| Fust Matthew K | Director | 07/26/2021 | 9,550 |
| Fust Matthew K | Director | 07/26/2021 | 97,950 |
| Fust Matthew K | Director | 07/19/2021 | 9,550 |
| Fust Matthew K | Director | 07/19/2021 | 97,500 |
| Fust Matthew K | Director | 07/12/2021 | 9,550 |
| Fust Matthew K | Director | 07/12/2021 | 103,550 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 04/08/2021 | 4,999,996 |
| Struthers Richard Scott | President & CEO | 12/02/2020 | 12,600 |
| Struthers Richard Scott | President & CEO | 12/03/2020 | 52,400 |
| Struthers Richard Scott | President & CEO | 07/16/2020 | 253,108 |
| Struthers Richard Scott | President & CEO | 07/15/2020 | 267,722 |
| WIERENGA WENDALL | Director | 04/28/2020 | 18,490 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 04/17/2020 | 14,999,992 |
| Vivo Capital VIII, LLC | 10% Owner | 04/15/2020 | 3,345,055 |
| Vivo Capital VIII, LLC | 10% Owner | 04/17/2020 | 1,302,809 |
| Vivo Capital VIII, LLC | 10% Owner | 04/16/2020 | 458,888 |
| Vivo Capital VIII, LLC | 10% Owner | 04/07/2020 | 86,833 |
| Vivo Capital VIII, LLC | 10% Owner | 04/03/2020 | 4,140,000 |
| Vivo Capital VIII, LLC | 10% Owner | 03/09/2020 | 10,296 |
| Vivo Capital VIII, LLC | 10% Owner | 02/10/2020 | 161,677 |
| Vivo Capital VIII, LLC | 10% Owner | 02/07/2020 | 129,910 |
| Vivo Capital VIII, LLC | 10% Owner | 02/04/2020 | 306,888 |
| Vivo Capital VIII, LLC | 10% Owner | 01/31/2020 | 117,180 |
| Vivo Capital VIII, LLC | 10% Owner | 01/30/2020 | 167,960 |
| Vivo Capital VIII, LLC | 10% Owner | 01/29/2020 | 309,024 |
| Fust Matthew K | Director | 12/16/2019 | 6,685 |
| Fust Matthew K | Director | 12/16/2019 | 78,750 |
| Struthers Richard Scott | President & CEO | 08/05/2019 | 19,100 |
| 5AM Ventures IV, L.P. | Former 10% holder | 06/21/2019 | 5,550,000 |
| Vivo Capital VIII, LLC | 10% Owner | 03/20/2019 | 9,278,250 |
| 5AM Ventures IV, L.P. | 10% Owner | 03/18/2019 | 3,754,954 |
| 5AM Ventures IV, L.P. | 10% Owner | 01/22/2019 | 5,734,597 |
| PERCEPTIVE ADVISORS LLC | Director | 07/20/2018 | 6,800,000 |
| PERCEPTIVE ADVISORS LLC | Director | 07/18/2018 | 6,552,902 |
| 5AM Ventures IV, L.P. | 10% Owner | 07/20/2018 | 1,955,000 |
| PERCEPTIVE ADVISORS LLC | Director | 07/20/2018 | 6,800,000 |
| Vivo Capital VIII, LLC | 10% Owner | 07/20/2018 | 6,575,421 |
| Krasner Alan Seth | Chief Medical Officer | 07/20/2018 | 34,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CRINETICS PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 5,345,114 | 0.00485% | 10.31% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 5,039,957 | 2.16% | -1.8% | Growth |
| ORBIMED ADVISORS LLC | 1,667,360 | 1.18% | -42.43% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,352,672 | 0.00504% | 6.54% | Other |
| FISHER ASSET MANAGEMENT, LLC | 441,295 | 0.0083% | 719.34% | Other |
| VIVO CAPITAL, LLC | 350,000 | 1.29% | No change | Other |
| CANDRIAM S.C.A. | 288,011 | 0.07% | New | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 122,904 | 0.02% | -66.04% | Event Driven, Value |
| ALPS ADVISORS INC | 46,025 | 0.01% | 14.13% | Other |
| TUDOR INVESTMENT CORP ET AL | 39,764 | 0.01% | 20.5% | Event Driven, Other |
| UBS OCONNOR LLC | 30,000 (Call) | 0.00485% | -50% | Value |
| D. E. SHAW & CO., INC. | 17,005 | 0.00053% | -63.39% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 11,700 | 0.00064% | -92.85% | Other |
| UBS OCONNOR LLC | 10,038 | 0.03% | -61.62% | Value |
| AQR CAPITAL MANAGEMENT LLC | 6,686 | 0.00045% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR CRINETICS PHARMACEUTICALS INC
STOCK BUYBACKS FOR CRINETICS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
18.43%
1Q
06/30/2023
23.95%
2Q
03/31/2023
24.80%
3Q
12/31/2022
24.91%
4Q
09/30/2022
25.12%
5Q
06/30/2022
28.09%
6Q
03/31/2022
41.00%
7Q
12/31/2021
48.50%
8Q
09/30/2021
75.61%
9Q
06/30/2021
81.53%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CRINETICS PHARMACEUTICALS INC
LOADING...